The establishment license is for the manufacturing, testing and packaging of the following drug dosage forms; capsules, powders, solutions and tablets.
The establishment license was issued after a good manufacturing practices inspection was conducted under the authority of the Food and Drugs Act to verify compliance with the applicable regulations.
The 46,400 sq ft Sydney facility includes pilot laboratories for formulation development, rooms with various capabilities such as high shear mixing, container blending and equipment for modified release technology. The facility provides formulation development and testing services to manufacture and package products in solid and liquid dosage forms.